Sterling Capital Management LLC Has $768,000 Stock Position in Guardian Pharmacy Services, Inc. $GRDN

Sterling Capital Management LLC reduced its holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 70.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,404 shares of the company’s stock after selling 48,616 shares during the period. Sterling Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $768,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Valiant Capital Management L.P. boosted its position in shares of Guardian Pharmacy Services by 15.8% in the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock valued at $37,085,000 after acquiring an additional 167,741 shares during the period. Wellington Management Group LLP grew its position in Guardian Pharmacy Services by 3.3% in the 3rd quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock worth $30,000,000 after purchasing an additional 36,072 shares during the last quarter. Franklin Resources Inc. raised its position in shares of Guardian Pharmacy Services by 8.2% during the third quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock valued at $27,705,000 after buying an additional 80,033 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock valued at $27,675,000 after buying an additional 88,296 shares during the last quarter. Finally, Boston Partners increased its stake in Guardian Pharmacy Services by 0.7% during the fourth quarter. Boston Partners now owns 1,054,636 shares of the company’s stock valued at $31,995,000 after acquiring an additional 7,759 shares during the period.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on GRDN. Truist Financial lifted their price target on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Oppenheimer increased their price objective on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Jefferies Financial Group initiated coverage on shares of Guardian Pharmacy Services in a research report on Monday, March 30th. They set a “buy” rating and a $44.00 target price on the stock. Finally, UBS Group reissued a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $42.83.

Guardian Pharmacy Services Stock Performance

NYSE:GRDN opened at $42.23 on Thursday. The company has a market cap of $2.10 billion, a price-to-earnings ratio of 50.87, a P/E/G ratio of 2.75 and a beta of 0.05. The stock’s fifty day moving average price is $39.02 and its two-hundred day moving average price is $35.22. Guardian Pharmacy Services, Inc. has a 52-week low of $19.30 and a 52-week high of $44.00.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.24 by $0.05. The company had revenue of $336.60 million during the quarter, compared to analysts’ expectations of $329.89 million. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The business’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same period last year, the firm earned $0.22 EPS. On average, equities analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.